TrialEuropean journal of clinical pharmacology2026

The Effect of the combination therapy of statin and dapagliflozin, a selective inhibitor of sodium_glucose Co-transporter type 2, in the treatment of Ischemic heart disease with heart failure: A randomized controlled trial.

Asmaa M Abdelkader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.